What is it about?
Good glycemic control can delay the progression of kidney diseases in type 2 diabetes mellitus (T2DM) patients with renal complications. To date, the association between antidiabetic agents and glycemic control in this specific patient population is not well established.
Featured Image
Why is it important?
This study aimed to identify antidiabetic regimens as well as other factors that associated with glycemic control in T2DM patients with different stages of chronic kidney disease (CKD).
Read the Original
This page is a summary of: Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications, Drug Design Development and Therapy, August 2015, Dove Medical Press,
DOI: 10.2147/dddt.s85676.
You can read the full text:
Contributors
The following have contributed to this page
